Search for drugs:

TECOVIRIMAT MONOHYDRATE


DIR Classification


Classification:Ambiguous
Severity Score:1.0

Description in Drug Labeling: View Full Labeling: SPL in DailyMed | PDF

  • CLINICAL PHARMACOLOGY
  • Pharmacodynamics
  • Cardiac Electrophysiology
  • TPOXX does not prolong the QT interval to any clinically relevant extent at the anticipated therapeutic exposure.

Postmarketing Surveillance

Contingency Table:

Current Drug
Other Drugs
QT Prolongation
0
24092
Other ADRs
0
38381587

Odds Ratio = N/A

Drug Property Information



ATC Code(s):
  • J05AX24 - tecovirimat monohydrate
    • J05AX - Other antivirals
    • J05A - DIRECT ACTING ANTIVIRALS
    • J05 - ANTIVIRALS FOR SYSTEMIC USE
    • J - ANTIINFECTIVES FOR SYSTEMIC USE
Active Ingredient:TECOVIRIMAT MONOHYDRATE
Active Ingredient UNII:SB96YO2BR8
Drugbank ID:DB12020
PubChem Compound:16124688
CTD ID:C505045
PharmGKB:
CAS Number:869572-92-9
Dosage Form(s):capsule
Route(s) Of Administrator:oral
Daily Dose:
Chemical Structure:
SMILE Code:
FC(F)(F)C1=CC=C(C=C1)C(=O)NN1C(=O)[C@H]2[C@H]([C@H]3C=C[C@@H]2[C@@H]2C[C@H]32)C1=O

Reference

N/A

Disclaimer:

The content of this database of QT prolongation is intended for educational and scientific research purposes only. It is not intended as a substitute for professional medical advice, diagnosis or treatment.

Any mention of commercial products is for clarification and not intended as endorsement.